EMA Authorised: Sialanar (glycopyrronium bromide) — Proveca Pharma Limited

View source ↗

Summary

The EMA authorised Sialanar (glycopyrronium bromide) by Proveca Pharma Limited for the treatment of sialorrhea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sialorrhea

Drugs mentioned

• Sialanar (glycopyrronium bromide)

Snippet

Status: Authorised. Therapeutic area: Sialorrhea. MAH: Proveca Pharma Limited. Decision date: 10/04/2025